KEYNOTE-799: Phase 2 trial of pembrolizumab plus platinum chemotherapy and radiotherapy for unresectable, locally advanced, stage 3 NSCLC.
Salma K. Jabbour,Ki Hyeong Lee,Nicolaj Frost,Valeriy Vladimirovich Breder,Dariusz M. Kowalski, Issam Abdelkarim Alawin,Evgeny Levchenko,Noemi Reguart,Alex Martinez-Marti, Baerin Houghton, Jean-Baptiste Paoli,Sufia Safina,Keunchil Park,Takefumi Komiya,Amy Sanford,Vishal Boolell,Hong Liu,Ayman Samkari,Steven M. Keller,Martin Reck JOURNAL OF CLINICAL ONCOLOGY（2021）
AI 理解论文
溯源树
样例
